D Rades

Summary

Country: Germany

Publications

  1. ncbi Do elderly patients benefit from surgery in addition to radiotherapy for treatment of metastatic spinal cord compression?
    D Rades
    Department of Radiation Oncology, University of Lubeck, Ratzeburger Allee 160, 23538, Lubeck, Germany
    Strahlenther Onkol 188:424-30. 2012
  2. ncbi Single brain metastasis: Radiosurgery alone compared with radiosurgery plus up-front whole-brain radiotherapy
    Dirk Rades
    Department of Radiation Oncology, University of Lubeck, Lubeck, Germany
    Cancer 118:2980-5. 2012
  3. ncbi Single brain metastasis: resection followed by whole-brain irradiation and a boost to the metastatic site compared to whole-brain irradiation plus radiosurgery
    Dirk Rades
    Department of Radiation Oncology, University of Lubeck, Ratzeburger Allee 160, D 23538 Luebeck, Germany
    Clin Neurol Neurosurg 114:326-30. 2012
  4. ncbi Prognostic factors in a series of 504 breast cancer patients with metastatic spinal cord compression
    D Rades
    Department of Radiation Oncology, University Hospital Schleswig Holstein, Ratzeburger Allee 160, 23538, Lubeck, Germany
    Strahlenther Onkol 188:340-5. 2012
  5. ncbi Cisplatin superior to carboplatin in adjuvant radiochemotherapy for locally advanced cancers of the oropharynx and oral cavity
    D Rades
    Department of Radiation Oncology, University of Lubeck, Ratzeburger Allee 160, 23538, Lubeck, Germany
    Strahlenther Onkol 188:42-8. 2012
  6. ncbi Single brain metastasis: whole-brain irradiation plus either radiosurgery or neurosurgical resection
    Dirk Rades
    Department of Radiation Oncology, University of Lubeck, Lubeck, Germany
    Cancer 118:1138-44. 2012
  7. ncbi Dose escalation of radiotherapy for metastatic spinal cord compression (MSCC) in patients with relatively favorable survival prognosis
    Dirk Rades
    Department of Radiation Oncology, University of Lubeck, Lubeck, Germany
    Strahlenther Onkol 187:729-35. 2011
  8. ncbi Prognostic factors for outcomes after whole-brain irradiation of brain metastases from relatively radioresistant tumors: a retrospective analysis
    Thekla Meyners
    Department of Radiation Oncology, University of Lubeck, Germany
    BMC Cancer 10:582. 2010
  9. ncbi Toxicity of two cisplatin-based radiochemotherapy regimens for the treatment of patients with stage III/IV head and neck cancer
    Dirk Rades
    Department of Radiation Oncology, University Hospital Schleswig Holstein, Campus Luebeck, Luebeck, Germany
    Head Neck 30:235-41. 2008
  10. ncbi Reduction of overall treatment time in patients irradiated for more than three brain metastases
    Dirk Rades
    Department of Radiation Oncology, University Hospital Schleswig Holstein, Luebeck, Germany
    Int J Radiat Oncol Biol Phys 69:1509-13. 2007

Detail Information

Publications113 found, 100 shown here

  1. ncbi Do elderly patients benefit from surgery in addition to radiotherapy for treatment of metastatic spinal cord compression?
    D Rades
    Department of Radiation Oncology, University of Lubeck, Ratzeburger Allee 160, 23538, Lubeck, Germany
    Strahlenther Onkol 188:424-30. 2012
    ....
  2. ncbi Single brain metastasis: Radiosurgery alone compared with radiosurgery plus up-front whole-brain radiotherapy
    Dirk Rades
    Department of Radiation Oncology, University of Lubeck, Lubeck, Germany
    Cancer 118:2980-5. 2012
    ..It was demonstrated that whole-brain radiotherapy (WBRT) in addition to RS improves local control of 1-3 brain metastases. Little information is available regarding WBRT in addition to RS for a single lesion...
  3. ncbi Single brain metastasis: resection followed by whole-brain irradiation and a boost to the metastatic site compared to whole-brain irradiation plus radiosurgery
    Dirk Rades
    Department of Radiation Oncology, University of Lubeck, Ratzeburger Allee 160, D 23538 Luebeck, Germany
    Clin Neurol Neurosurg 114:326-30. 2012
    ..This matched-pair analysis compared whole-brain irradiation plus radiosurgery (WBI+RS) to neurosurgical resection followed by whole-brain irradiation and a boost to the metastatic site (NR+WBI+B)...
  4. ncbi Prognostic factors in a series of 504 breast cancer patients with metastatic spinal cord compression
    D Rades
    Department of Radiation Oncology, University Hospital Schleswig Holstein, Ratzeburger Allee 160, 23538, Lubeck, Germany
    Strahlenther Onkol 188:340-5. 2012
    ..This study was performed to identify new significant prognostic factors in breast cancer patients irradiated for metastatic spinal cord compression (MSCC)...
  5. ncbi Cisplatin superior to carboplatin in adjuvant radiochemotherapy for locally advanced cancers of the oropharynx and oral cavity
    D Rades
    Department of Radiation Oncology, University of Lubeck, Ratzeburger Allee 160, 23538, Lubeck, Germany
    Strahlenther Onkol 188:42-8. 2012
    ..This retrospective study compared radiochemotherapy with either cisplatin or carboplatin in patients with locally advanced SCC of the oropharynx and oral cavity...
  6. ncbi Single brain metastasis: whole-brain irradiation plus either radiosurgery or neurosurgical resection
    Dirk Rades
    Department of Radiation Oncology, University of Lubeck, Lubeck, Germany
    Cancer 118:1138-44. 2012
    ..The current study was conducted to compare neurosurgical resection (NR) followed by whole-brain irradiation (WBI) (NR + WBI) with WBI followed by radiosurgery (WBI + RS) in patients with a single brain metastasis...
  7. ncbi Dose escalation of radiotherapy for metastatic spinal cord compression (MSCC) in patients with relatively favorable survival prognosis
    Dirk Rades
    Department of Radiation Oncology, University of Lubeck, Lubeck, Germany
    Strahlenther Onkol 187:729-35. 2011
    ..The most frequently used schedule world wide is 30 Gy/10 fractions. This study investigated whether patients with favorable survival prognoses benefit from a dose escalation beyond 30 Gy...
  8. ncbi Prognostic factors for outcomes after whole-brain irradiation of brain metastases from relatively radioresistant tumors: a retrospective analysis
    Thekla Meyners
    Department of Radiation Oncology, University of Lubeck, Germany
    BMC Cancer 10:582. 2010
    ..Additionally, a potential benefit from escalating the radiation dose was investigated...
  9. ncbi Toxicity of two cisplatin-based radiochemotherapy regimens for the treatment of patients with stage III/IV head and neck cancer
    Dirk Rades
    Department of Radiation Oncology, University Hospital Schleswig Holstein, Campus Luebeck, Luebeck, Germany
    Head Neck 30:235-41. 2008
    ..This nonrandomized study compared 2 radiochemotherapy regimens for toxicity in 128 patients with stage III/IV head and neck cancer...
  10. ncbi Reduction of overall treatment time in patients irradiated for more than three brain metastases
    Dirk Rades
    Department of Radiation Oncology, University Hospital Schleswig Holstein, Luebeck, Germany
    Int J Radiat Oncol Biol Phys 69:1509-13. 2007
    ..Regarding the poor survival of these patients, a shorter RT regimen would be preferable if it provides a similar outcome as that with 10 x 3 Gy. This study compared 20 Gy in five fractions (5 x 4 Gy) within 5 days to 10 x 3 Gy...
  11. ncbi Prognostic factors affecting locally recurrent rectal cancer and clinical significance of hemoglobin
    Dirk Rades
    Department of Radiation Oncology, University Hospital Schleswig Holstein, Campus Luebeck, Luebeck, Germany
    Int J Radiat Oncol Biol Phys 70:1087-93. 2008
    ..To investigate potential prognostic factors, including hemoglobin levels before and during radiotherapy, for associations with survival and local control in patients with unirradiated locally recurrent rectal cancer...
  12. ncbi Surgical resection followed by whole brain radiotherapy versus whole brain radiotherapy alone for single brain metastasis
    Dirk Rades
    Department of Radiation Oncology, University Hospital Schleswig Holstein, Luebeck, Germany
    Int J Radiat Oncol Biol Phys 70:1319-24. 2008
    ..To compare the outcome of surgical resection followed by whole brain radiotherapy (WBRT) with WBRT alone in patients treated for single brain metastasis...
  13. ncbi Evaluation of 2 whole-brain radiotherapy schedules and prognostic factors for brain metastases in breast cancer patients
    Dirk Rades
    Department of Radiation Oncology, University Hospital Schleswig Holstein, Luebeck, Germany
    Cancer 110:2587-92. 2007
    ..This retrospective study compared survival and local control within the brain resulting from short-course WBRT with longer programs in 207 breast cancer patients...
  14. ncbi The impact of tumor expression of erythropoietin receptors and erythropoietin on clinical outcome of esophageal cancer patients treated with chemoradiation
    Dirk Rades
    Department of Radiation Oncology, University Medical Center Hamburg Eppendorf, Hamburg, Germany
    Int J Radiat Oncol Biol Phys 71:152-9. 2008
    ..To investigate the impact of tumor erythropoietin receptors (Epo-R) and erythropoietin (Epo) expression in 64 patients with Stage III esophageal cancer receiving or not receiving erythropoietin during chemoradiation...
  15. ncbi Effect of smoking during radiotherapy, respiratory insufficiency, and hemoglobin levels on outcome in patients irradiated for non-small-cell lung cancer
    Dirk Rades
    Department of Radiation Oncology, University Hospital Schleswig Holstein, Campus Luebeck, Luebeck, Germany
    Int J Radiat Oncol Biol Phys 71:1134-42. 2008
    ....
  16. ncbi A boost in addition to whole-brain radiotherapy improves patient outcome after resection of 1 or 2 brain metastases in recursive partitioning analysis class 1 and 2 patients
    Dirk Rades
    Department of Radiation Oncology, University Hospital Schleswig Holstein, Campus Luebeck, Germany
    Cancer 110:1551-9. 2007
    ..The current study was conducted to compare 2 treatment regimens including surgical resection and whole-brain radiotherapy (WBRT) for patients with 1 to 2 brain metastases...
  17. ncbi Experiences with a new high-dose-rate brachytherapy (HDR-BT) boost technique for T3b prostate cancer
    Dirk Rades
    Department of Radiation Oncology, University Medical Center Hamburg Eppendorf, Germany
    Strahlenther Onkol 183:398-402. 2007
    ..Experiences with a new high-dose-rate brachytherapy (HDR-BT) boost technique in 41 patients with stage T3b prostate cancer are presented...
  18. ncbi Is 50 Gy sufficient to achieve long-term local control after incomplete resection of typical neurocytomas?
    Dirk Rades
    Department of Radiation Oncology, University Hospital Hamburg Eppendorf, Hamburg, Germany
    Strahlenther Onkol 182:415-8. 2006
    ..Typical neurocytomas are associated with better outcome. This study investigates whether a decrease in radiation dose from 54 Gy to 50 Gy for incompletely resected typical neurocytomas would jeopardize the outcome...
  19. ncbi Prognostic factors for local control and survival after radiotherapy of metastatic spinal cord compression
    Dirk Rades
    Department of Radiation Oncology, University Hospital Hamburg Eppendorf, Germany
    J Clin Oncol 24:3388-93. 2006
    ..To evaluate potential prognostic factors for local control and survival after radiotherapy of metastatic spinal cord compression (MSCC)...
  20. ncbi Prognostic factors in head-and-neck cancer patients treated with surgery followed by intensity-modulated radiotherapy (IMRT), 3D-conformal radiotherapy, or conventional radiotherapy
    Dirk Rades
    Department of Radiation Oncology, University Medical Center Hamburg Eppendorf, 20246 Hamburg, Germany
    Oral Oncol 43:535-43. 2007
    ..The three radiation techniques provided similar disease control. IMRT was effective in significantly reducing xerostomia...
  21. ncbi Functional outcome and survival after radiotherapy of metastatic spinal cord compression in patients with cancer of unknown primary
    Dirk Rades
    Department of Radiation Oncology, University Hospital Schleswig Holstein, Luebeck, Germany
    Int J Radiat Oncol Biol Phys 67:532-7. 2007
    ..Patients with cancer of unknown primary (CUP) account for about 10% of patients with metastatic spinal cord compression (MSCC). This study aims to define the appropriate radiation regimen for these patients...
  22. ncbi Is short-course radiotherapy with high doses per fraction the appropriate regimen for metastatic spinal cord compression in colorectal cancer patients?
    Dirk Rades
    Department of Radiation Oncology, University Hospital Schleswig Holstein, Campus Luebeck, Luebeck, Germany
    Strahlenther Onkol 182:708-12. 2006
    ..5 Gy given in 3 weeks, 20 x 2 Gy given in 4 weeks) and whether higher doses per fraction (more cell kill) and shorter overall treatment time (less repopulation) can compensate for lower total doses...
  23. ncbi Radiotherapy is effective for metastatic spinal cord compression in patients with epithelial ovarian cancer
    D Rades
    Department of Radiation Oncology, University Hospital Schleswig Holstein, Ratzeburger Allee 160, 23538 Luebeck, Germany
    Int J Gynecol Cancer 17:263-5. 2007
    ..A recurrence of MSCC did not occur. Radiotherapy alone is effective in improving or maintaining motor function in MSCC patients with ovarian cancer and should be administered if decompressive surgery is not indicated...
  24. ncbi High accuracy of virtual simulation with the laser system Dorado CT4
    Dirk Rades
    Department of Radiation Oncology, University Medical Center, Hamburg Eppendorf, Germany
    Strahlenther Onkol 183:89-93. 2007
    ..To evaluate the accuracy of virtual simulation, which is less time-consuming than physical simulation, with the new laser system Dorado CT4 in 96 prostate cancer patients...
  25. ncbi Stereotactic radiosurgery alone versus resection plus whole-brain radiotherapy for 1 or 2 brain metastases in recursive partitioning analysis class 1 and 2 patients
    Dirk Rades
    Department of Radiation Oncology, University Hospital Schleswig Holstein, Campus Luebeck, Germany
    Cancer 109:2515-21. 2007
    ....
  26. ncbi A new scoring system to predicting the survival of patients treated with whole-brain radiotherapy for brain metastases
    Dirk Rades
    Department of Radiation Oncology, University Hospital Schleswig Holstein, Luebeck, Germany
    Strahlenther Onkol 184:251-5. 2008
    ..To create a scoring system to estimate survival of patients who received whole-brain radiotherapy (WBRT) for brain metastases...
  27. ncbi Prognostic factors for functional outcome and survival after reirradiation for in-field recurrences of metastatic spinal cord compression
    Dirk Rades
    Department of Radiation Oncology, University Hospital Schleswig Holstein, Luebeck, Germany
    Cancer 113:1090-6. 2008
    ..The purpose of the current study was to retrospectively investigate clinical outcome and potential prognostic factors after reirradiation (Re-RT) for in-field recurrence of metastatic spinal cord compression (MSCC)...
  28. ncbi A matched-pair analysis comparing whole-brain radiotherapy plus stereotactic radiosurgery versus surgery plus whole-brain radiotherapy and a boost to the metastatic site for one or two brain metastases
    Dirk Rades
    Department of Radiation Oncology, University Hospital Schleswig Holstein, Campus Luebeck, Luebeck, Germany
    Int J Radiat Oncol Biol Phys 73:1077-81. 2009
    ....
  29. ncbi Prognostic factors (including HPV status) for irradiation of locally advanced squamous cell carcinoma of the head and neck (SCCHN)
    Dirk Rades
    Department of Radiation Oncology, University of Lubeck, Germany
    Strahlenther Onkol 187:626-32. 2011
    ..This study investigated potential prognostic factors, including HPV status, for locoregional control (LRC), metastases-free survival (MFS), and survival (OS)...
  30. ncbi Comparison of radiochemotherapy alone to surgery plus radio(chemo)therapy for non-metastatic stage III/IV squamous cell carcinoma of the head and neck: A matched-pair analysis
    Dirk Rades
    Department of Radiation Oncology, University of Lubeck, Lubeck, Germany
    Strahlenther Onkol 187:541-7. 2011
    ..This study compared the outcomes of radiochemotherapy alone to surgery followed by radio(chemo)therapy (radiotherapy plus/minus concurrent chemotherapy)...
  31. ncbi The prognostic impact of tumor cell expression of estrogen receptor-?, progesterone receptor, and androgen receptor in patients irradiated for nonsmall cell lung cancer
    Dirk Rades
    Department of Radiation Oncology, University of Lubeck, Lubeck, Germany
    Cancer 118:157-63. 2012
    ....
  32. ncbi Shorter-course whole-brain radiotherapy for brain metastases in elderly patients
    Dirk Rades
    Department of Radiation Oncology, University Hospital Schleswig Holstein, Lubeck, Germany
    Int J Radiat Oncol Biol Phys 81:e469-73. 2011
    ..Regarding the extraordinarily poor survival prognosis of elderly patients with multiple brain metastases, a shorter WBRT regimen would be preferable. This study compared 10 × 3 Gy with 5 × 4 Gy in elderly patients (?65 years)...
  33. ncbi Fibroblast growth factor 2--a predictor of outcome for patients irradiated for stage II-III non-small-cell lung cancer
    Dirk Rades
    Department of Radiation Oncology, University of Lubeck, Lubeck, Germany
    Int J Radiat Oncol Biol Phys 82:442-7. 2012
    ..The present study investigated the effect of tumor cell expression of FGF-2 on the outcome of 60 patients irradiated for Stage II-III NSCLC...
  34. ncbi Radiolabeled cetuximab plus whole-brain irradiation (WBI) for the treatment of brain metastases from non-small cell lung cancer (NSCLC)
    Dirk Rades
    Department of Radiation Oncology, University of Lubeck, Lubeck, Germany
    Strahlenther Onkol 186:458-62. 2010
    ..Radiolabeling of cetuximab was performed to investigate whether this antibody crosses the BBB...
  35. ncbi Prognostic impact of erythropoietin expression and erythropoietin receptor expression on locoregional control and survival of patients irradiated for stage II/III non-small-cell lung cancer
    Dirk Rades
    Department of Radiation Oncology, University of Lubeck, Germany
    Int J Radiat Oncol Biol Phys 80:499-505. 2011
    ..This study investigates the prognostic value of erythropoietin (EPO) and EPO receptor (EPO-R) expression of tumor cells for locoregional control and survival in non-small-cell lung cancer (NSCLC) patients...
  36. ncbi Comparison of four cisplatin-based radiochemotherapy regimens for nonmetastatic stage III/IV squamous cell carcinoma of the head and neck
    Dirk Rades
    Department of Radiation Oncology, University of Lubeck, Lubeck, Germany
    Int J Radiat Oncol Biol Phys 80:1037-44. 2011
    ..To compare the outcomes of four cisplatin-based radiochemotherapy regimens in 311 patients with Stage III/IV squamous cell carcinoma of the head and neck...
  37. ncbi Matched pair analysis comparing surgery followed by radiotherapy and radiotherapy alone for metastatic spinal cord compression
    Dirk Rades
    University of Lubeck, Lubeck, Germany
    J Clin Oncol 28:3597-604. 2010
    ..That study was limited to highly selected patients. Additional studies comparing surgery plus radiotherapy to radiotherapy could better clarify the role of surgery...
  38. ncbi Dose escalation for metastatic spinal cord compression in patients with relatively radioresistant tumors
    Dirk Rades
    Department of Radiation Oncology, University of Lubeck, Germany
    Int J Radiat Oncol Biol Phys 80:1492-7. 2011
    ..However, the results of the "standard" regimen 30 Gy/10 fractions need to be improved with respect to functional outcome. This study investigated whether a dose escalation beyond 30 Gy can improve treatment outcomes...
  39. ncbi Do patients receiving whole-brain radiotherapy for brain metastases from renal cell carcinoma benefit from escalation of the radiation dose?
    Dirk Rades
    Department of Radiation Oncology, University Hospital Schleswig Holstein, Lubeck, Germany
    Int J Radiat Oncol Biol Phys 78:398-403. 2010
    ..The standard WBRT regimen, 30 Gy/10 fractions (10 × 3 Gy), has resulted in poor survival (OS). This study investigates whether escalation of the WBRT dose improves treatment outcomes...
  40. ncbi Final results of a prospective study comparing the local control of short-course and long-course radiotherapy for metastatic spinal cord compression
    Dirk Rades
    Department of Radiation Oncology, University of Lubeck, Germany
    Int J Radiat Oncol Biol Phys 79:524-30. 2011
    ..This is the first prospective study that has compared local control of different radiotherapy schedules for MSCC...
  41. ncbi Prognostic impact of VEGF and VEGF receptor 1 (FLT1) expression in patients irradiated for stage II/III non-small cell lung cancer (NSCLC)
    Dirk Rades
    Department of Radiation Oncology, University of Lubeck, Germany
    Strahlenther Onkol 186:307-14. 2010
    ..This study investigated the impact of tumor expression of VEGF and FLT1 on outcomes in 61 patients irradiated for stage II/III non-small cell lung cancer (NSCLC)...
  42. ncbi Acute toxicity of three versus two courses of cisplatin for radiochemotherapy of locally advanced squamous cell carcinoma of the head and neck (SCCHN): a matched pair analysis
    Dirk Rades
    Department of Radiation Oncology, University of Lubeck, Germany
    Oral Oncol 46:549-52. 2010
    ..001). At least one grade >or= 3 toxicity occurred in 90% of group A and 20% of group B patients, respectively (p=0.005). Two courses of fractionated cisplatin appeared much better tolerated than three courses of fractionated cisplatin...
  43. ncbi Treatment of painful bone metastases
    Dirk Rades
    Department of Radiation Oncology, University of Lubeck, Ratzeburger Allee 160, 23538 Lubeck, Germany
    Nat Rev Clin Oncol 7:220-9. 2010
    ..Thus, long-course multi-fraction radiotherapy should be reserved for patients with a relatively favorable survival prognosis...
  44. ncbi Comparison of stereotactic radiosurgery (SRS) alone and whole brain radiotherapy (WBRT) plus a stereotactic boost (WBRT+SRS) for one to three brain metastases
    Dirk Rades
    Department of Radiation Oncology, University Hospital Schleswig Holstein, Campus Luebeck, Germany
    Strahlenther Onkol 184:655-62. 2008
    ..The best available treatment of patients with one to three brain metastases is still unclear. This study compared the results of stereotactic radiosurgery (SRS) alone and whole brain radiotherapy (WBRT) plus SRS (WBRT+SRS)...
  45. ncbi The role of postoperative radiotherapy for the treatment of gangliogliomas
    Dirk Rades
    Department of Radiation Oncology, University of Lubeck, Ratzeburger Allee 160, D 23538 Lubeck, Germany
    Cancer 116:432-42. 2010
    ..The optimal treatment regimen is unclear. In this study, the authors compared 4 therapies for local control (LC) and overall survival (OS) in patients with ganglioglioma...
  46. ncbi Final results of a prospective study of the prognostic value of the time to develop motor deficits before irradiation in metastatic spinal cord compression
    Dirk Rades
    Department ofRadiation Oncology, Hannover Medical University, Hannover, Germany
    Int J Radiat Oncol Biol Phys 53:975-9. 2002
    ..Because only the type of primary tumor and pretreatment ambulatory status are known as prognostic factors for functional outcome, we investigated the prognostic value of the time of motor deficit development before radiotherapy (RT)...
  47. ncbi Spinal reirradiation after short-course RT for metastatic spinal cord compression
    Dirk Rades
    Department of Radiation Oncology, University Hospital Hamburg Eppendorf, Hamburg, Germany
    Int J Radiat Oncol Biol Phys 63:872-5. 2005
    ..To investigate the feasibility and effectiveness of reirradiation (re-RT) for in-field recurrence of metastatic spinal cord compression after primary RT with 1 x 8 Gy or 5 x 4 Gy...
  48. ncbi A prospective evaluation of two radiotherapy schedules with 10 versus 20 fractions for the treatment of metastatic spinal cord compression: final results of a multicenter study
    Dirk Rades
    Department of Radiation Oncology, University Hospital Hamburg, Hamburg, Germany
    Cancer 101:2687-92. 2004
    ..The current observational multicenter study, performed prospectively by the authors, evaluated two radiotherapy (RT) schedules and prognostic factors with respect to functional outcome..
  49. ncbi Epoetin-alpha during radiotherapy for stage III esophageal carcinoma
    Dirk Rades
    Department of Radiation Oncology, University Hospital Hamburg Eppendorf, Hamburg, Germany
    Cancer 103:2274-9. 2005
    ....
  50. ncbi Well-differentiated neurocytoma: what is the best available treatment?
    Dirk Rades
    Department of Radiation Oncology, University Hospital Hamburg Eppendorf, Hamburg, Germany
    Neuro Oncol 7:77-83. 2005
    ..A radiation dose of 54 Gy appeared sufficient. Application of postoperative radiotherapy should be decided individually, taking into account the risk of local failure, the need for another craniotomy, and potential radiation toxicity...
  51. ncbi Defining the best available treatment for neurocytomas in children
    Dirk Rades
    Department of Radiation Oncology, University Hospital Hamburg Eppendorf, Hamburg, Germany
    Cancer 101:2629-32. 2004
    ..Since this entity was introduced in 1982, approximately 60 cases have been reported among patients age </= =18 years of age. The current analysis was performed to define the best available neurocytoma therapy in children...
  52. ncbi Therapy of meningeal melanocytomas
    Dirk Rades
    Department of Radiation Oncology, University Hospital Hamburg Eppendorf, Hamburg, Germany
    Cancer 100:2442-7. 2004
    ..In the current study, four therapies were compared with regard to local control and survival to identify which is best...
  53. ncbi Prognostic value of the MIB-1 labeling index for central neurocytomas
    Dirk Rades
    Department of Radiation Oncology, University Hospital Hamburg Eppendorf, Hamburg, Germany
    Neurology 62:987-9. 2004
    ..Data were obtained not from the literature alone but also from contact with the authors. The data suggested an MIB-1 index score of >3% to be associated with a worse prognosis for local control (p < 0.0001) and survival (p = 0.0004)...
  54. ncbi Treatment of solitary brain metastasis. Resection followed by whole brain radiation therapy (WBRT) and a radiation boost to the metastatic site
    Dirk Rades
    Department of Radiotherapy and Radiooncology, University Hospital Hamburg Eppendorf, Germany
    Strahlenther Onkol 180:144-7. 2004
    ..The optimum radiation schedule has yet to be defined. The authors' experience with a postoperative approach including WBRT and a radiation boost to the metastatic site is presented...
  55. ncbi Treatment of atypical neurocytomas
    Dirk Rades
    Department of Radiation Oncology, University Hospital Hamburg Eppendorf, Hamburg, Germany
    Cancer 100:814-7. 2004
    ..The objective of this analysis was to define the optimal treatment for patients with these atypical tumors...
  56. ncbi [Treatment for central neurocytoma: a meta-analysis based on the data of 358 patients]
    Dirk Rades
    Abteilung für Strahlentherapie und Radioonkologie, Universitatsklinikum Hamburg Eppendorf, Hamburg, Deutschland
    Strahlenther Onkol 179:213-8. 2003
    ....
  57. ncbi Defining the optimal dose of radiation after incomplete resection of central neurocytomas
    Dirk Rades
    Department of Radiation Oncology, University Hospital Hamburg Eppendorf, Germany
    Int J Radiat Oncol Biol Phys 55:373-7. 2003
    ..Central neurocytomas are uncommon benign central nervous system tumors. There is uncertainty regarding the most appropriate radiation dose after incomplete resection. This analysis was performed to determine the optimal dose...
  58. ncbi Is there a dose-effect relationship for the treatment of symptomatic vertebral hemangioma?
    Dirk Rades
    Department of Radiation Oncology, University Hospital Eppendorf, Hamburg, Germany
    Int J Radiat Oncol Biol Phys 55:178-81. 2003
    ..Symptomatic vertebral hemangiomas are rare vascular lesions. Radiotherapy is the most common treatment. Because of a lack of information in the literature, uncertainty exists about the total radiation dose to be applied...
  59. ncbi The role of radiotherapy for metastatic epidural spinal cord compression
    Dirk Rades
    Department of Radiation Oncology, University of Lubeck, Ratzeburger Allee 160, 23538 Lubeck, Germany
    Nat Rev Clin Oncol 7:590-8. 2010
    ..Larger prospective trials are required to better define the appropriate treatment for the individual patient...
  60. ncbi Treatment options for central neurocytoma
    Dirk Rades
    Department of Radiation Oncology, University Hospital Hamburg Eppendorf, Hamburg, Germany
    Neurology 59:1268-70. 2002
    ..The data suggest that complete resection leads to significantly better local control and survival than incomplete resection. After incomplete resection, patients benefit from postoperative radiotherapy...
  61. ncbi A comparison of two different radiation schedules for metastatic spinal cord compression considering a new prognostic factor
    Dirk Rades
    Department of Radiation Oncology, Hannover Medical School, Hannover, Germany
    Strahlenther Onkol 178:556-61. 2002
    ..This analysis compares the effect of two schedules on motor function considering three relevant prognostic factors (type of primary tumor, pre-treatment ambulatory status, time of developing motor deficits before radiotherapy)...
  62. ncbi [Effectiveness and toxicity of reirradiation (Re-RT) for metastatic spinal cord compression (MSCC)]
    Dirk Rades
    Klinik und Poliklinik für Strahlentherapie und Radioonkologie, Universitatsklinikum, Hamburg Eppendorf
    Strahlenther Onkol 181:595-600. 2005
    ..Many radiation oncologists are concerned about spinal Re-RT, because it may result in a high cumulative EQD2. This study investigates effectiveness and feasibility of Re-RT for in-field recurrence of MSCC...
  63. ncbi Comparison of 1 x 8 Gy and 10 x 3 Gy for functional outcome in patients with metastatic spinal cord compression
    Dirk Rades
    Department of Radiation Oncology, University Hospital Hamburg Eppendorf, Hamburg, Germany
    Int J Radiat Oncol Biol Phys 62:514-8. 2005
    ..This study investigates a reduction of the overall treatment time to only one day by comparing 1 x 8 Gy to the multi-fractionated 10 x 3 Gy for functional outcome...
  64. ncbi Short-course radiotherapy is not optimal for spinal cord compression due to myeloma
    Dirk Rades
    Department of Radiation Oncology, University Hospital, Hamburg, Germany
    Int J Radiat Oncol Biol Phys 64:1452-7. 2006
    ..To investigate the suitability of short-course radiotherapy (RT) for spinal cord compression (SCC) in myeloma patients...
  65. ncbi Evaluation of functional outcome and local control after radiotherapy for metastatic spinal cord compression in patients with prostate cancer
    Dirk Rades
    Department of Radiation Oncology, University Hospital Hamburg Eppendorf, Hamburg, Germany
    J Urol 175:552-6. 2006
    ..This study investigates prognostic factors and radiation schedules for functional outcome and local control of MSCC after radiotherapy in patients with prostate cancer...
  66. ncbi Short-course radiotherapy (RT) for metastatic spinal cord compression (MSCC) due to renal cell carcinoma: results of a retrospective multi-center study
    Dirk Rades
    Department of Radiation Oncology, University Hospital Hamburg Eppendorf, Hamburg, Germany
    Eur Urol 49:846-52; discussion 852. 2006
    ..Our study compares short-course (1 x 8 Gy, 5 x 4 Gy) and long-course RT (10 x 3 Gy, 15 x 2.5 Gy, 20 x 2 Gy) for functional outcome in MSCC patients with renal cell carcinoma...
  67. ncbi Treatment recommendations for the various subgroups of neurocytomas
    Dirk Rades
    Department of Radiation Oncology, University Hospital Hamburg Eppendorf, Hamburg, Germany
    J Neurooncol 77:305-9. 2006
    ..In children, <or=50 Gy and >50 Gy were comparable.CTR does not require post-operative RT. Following ITR, RT improves outcome. Of 50-54 Gy appear sufficient for typical lesions, 50 Gy for children. Atypical lesions require 56-60 Gy...
  68. ncbi Dose-response relationship for fractionated irradiation in the treatment of spinal meningeal melanocytomas: a review of the literature
    Dirk Rades
    Department of Radiation Oncology, University Hospital Hamburg Eppendorf, Hamburg, Germany
    J Neurooncol 77:311-4. 2006
    ..The recurrence rates after CTR would mandate the use of post-operative radiotherapy in all spinal meningeal melanocytoma cases. Our results should be confirmed in a larger series of patients when available...
  69. ncbi Defining the appropriate radiotherapy regimen for metastatic spinal cord compression in non-small cell lung cancer patients
    Dirk Rades
    Department of Radiation Oncology, University Medical Center Hamburg Eppendorf, University Hospital Hamburg, Martinistr 52, D 20246 Hamburg, Germany
    Eur J Cancer 42:1052-6. 2006
    ..94). Short-course and long-course RT appear similarly effective for MSCC in NSCLC patients. As 1 x 8 Gy and 5 x 4 Gy showed comparable results, 1 x 8 Gy can be considered appropriate...
  70. ncbi Prognostic factors predicting functional outcomes, recurrence-free survival, and overall survival after radiotherapy for metastatic spinal cord compression in breast cancer patients
    Dirk Rades
    Department of Radiation Oncology, University Hospital Hamburg Eppendorf, Hamburg, Germany
    Int J Radiat Oncol Biol Phys 64:182-8. 2006
    ..To identify significant prognostic factors after irradiation of metastatic spinal cord compression (MSCC) in 335 breast cancer patients...
  71. ncbi Time of developing motor deficits before radiotherapy as a new and relevant prognostic factor in metastatic spinal cord compression: final results of a retrospective analysis
    D Rades
    Department of Radiation Oncology, Hannover Medical University, Hannover, Germany
    Eur Neurol 45:266-9. 2001
    ..001). A slower development of motor deficits predicts a better functional outcome. Time of developing motor deficits before RT is a relevant prognostic factor in metastatic spinal cord compression...
  72. ncbi Radiochemotherapy versus surgery plus radio(chemo)therapy for stage T3/T4 larynx and hypopharynx cancer - Results of a matched-pair analysis
    Dirk Rades
    Department of Radiation Oncology, University of Lubeck, Germany
    Eur J Cancer 47:2729-34. 2011
    ..Other toxicities were similar. Outcomes of radiochemotherapy appeared similar to those of surgery plus radio(chemo)therapy. The larynx preservation rate was higher after radiochemotherapy...
  73. ncbi Epoetin alfa improves survival after chemoradiation for stage III esophageal cancer: final results of a prospective observational study
    Dirk Rades
    Department of Radiation Oncology, University Hospital, Hamburg, Germany
    Int J Radiat Oncol Biol Phys 65:459-65. 2006
    ..18% at 2 years, p = 0.09). CONCLUSIONS: The findings suggest that epoetin alfa when used to maintain the hemoglobin levels at 12 to 14 g/dL can improve OS and LC of Stage III esophageal cancer patients...
  74. ncbi Radiotherapy for oligometastatic disease in patients with spinal cord compression (MSCC) from relatively radioresistant tumors
    Katja Freundt
    Department of Radiation Oncology, University of Lubeck, Lubeck, Germany
    Strahlenther Onkol 186:218-23. 2010
    ..If such therapies are not available, one can speculate whether patients benefit from dose escalation beyond the standard regimen 30 Gy in ten fractions...
  75. ncbi Radiochemotherapy including cisplatin alone versus cisplatin + 5-fluorouracil for locally advanced unresectable stage IV squamous cell carcinoma of the head and neck
    Silke Tribius
    Department of Radiation Oncology, University Medical Center Hamburg Eppendorf, Hamburg, Germany
    Strahlenther Onkol 185:675-81. 2009
    ..This nonrandomized study compares two cisplatin-based radiochemotherapy regimens in 128 patients with locally advanced unresectable stage IV squamous cell carcinoma of the head and neck (SCCHN)...
  76. ncbi Radio(chemo)therapy plus resection versus radio(chemo)therapy alone for the treatment of stage III esophageal cancer
    Dirk Rades
    Department of Radiation Oncology, University Hospital Schleswig Holstein, Campus Luebeck, Luebeck, Germany
    Strahlenther Onkol 183:10-6. 2007
    ..4-66.6 Gy (higher dose, HD-RCT) alone for outcome in stage III esophageal cancer, and to investigate potential prognostic factors including preradiotherapy (pre-RT) hemoglobin...
  77. ncbi A score predicting posttreatment ambulatory status in patients irradiated for metastatic spinal cord compression
    Dirk Rades
    Department of Radiation Oncology, University Hospital Schleswig Holstein, Luebeck, Germany
    Int J Radiat Oncol Biol Phys 72:905-8. 2008
    ..To create a scoring system to predict ambulatory status after radiotherapy (RT) for metastatic spinal cord compression (MSCC)...
  78. ncbi Dose escalation in patients receiving whole-brain radiotherapy for brain metastases from colorectal cancer
    Christine Heisterkamp
    Department of Radiation Oncology, University Hospital Schleswig Holstein, Lubeck, Germany
    Strahlenther Onkol 186:70-5. 2010
    ..The standard WBRT regimen, 30 Gy in ten fractions (10 x 3 Gy), has generally resulted in poor outcomes. This study investigated whether an escalation of the WBRT dose improves these results...
  79. ncbi Whole-brain radiotherapy with 20 Gy in 5 fractions for brain metastases in patients with cancer of unknown primary (CUP)
    Dirk Rades
    Department of Radiation Oncology, University Hospital Schleswig Holstein, Luebeck, Germany
    Strahlenther Onkol 183:631-6. 2007
    ..This study compares short-course RT with 20 Gy in 5 fractions (5 x 4 Gy) given over 5 days to longer programs in CUP patients...
  80. ncbi Radioactive EGFR antibody cetuximab in multimodal cancer treatment: stability and synergistic effects with radiotherapy
    Dirk Rades
    Department of Radiation Oncology, University of Luebeck, Luebeck, Germany
    Int J Radiat Oncol Biol Phys 75:1226-31. 2009
    ..This study investigated the stability of radiolabeled cetuximab (Erbitux) ((131)I-Erbi) and potential synergistic effects with radiotherapy in vitro...
  81. ncbi Preliminary results of spinal cord compression recurrence evaluation (score-1) study comparing short-course versus long-course radiotherapy for local control of malignant epidural spinal cord compression
    Dirk Rades
    Department of Radiation Oncology, University Hospital Lubeck, Lubeck, Germany
    Int J Radiat Oncol Biol Phys 73:228-34. 2009
    ..To compare the results of short-course vs. long-course radiotherapy (RT) for metastatic spinal cord compression...
  82. ncbi Short-course whole-brain radiotherapy (WBRT) for brain metastases due to small-cell lung cancer (SCLC)
    Guenther Bohlen
    Department of Radiation Oncology, University of Lubeck, Lubeck, Germany
    Clin Neurol Neurosurg 112:183-7. 2010
    ..The most common treatment is whole-brain radiotherapy (WBRT). This retrospective study compares short-course WBRT with 5x4Gy in 1 week to standard WBRT with 10x3Gy in 2 weeks...
  83. ncbi Localised disease in cancer of unknown primary (CUP): the value of positron emission tomography (PET) for individual therapeutic management
    D Rades
    Department of Radiation Oncology, Hannover Medical College, Germany
    Ann Oncol 12:1605-9. 2001
    ..After conservative diagnostic procedures including MRI, the primary is detected in less than 25%. The diagnostic value of PET and its influence on therapeutic strategies was evaluated...
  84. ncbi Prognostic significance of the time of developing motor deficits before radiation therapy in metastatic spinal cord compression: one-year results of a prospective trial
    D Rades
    Department of Radiation Oncology, Hannover Medical University, Hannover, Germany
    Int J Radiat Oncol Biol Phys 48:1403-8. 2000
    ..To investigate prospectively the prognostic value of the time of developing motor deficits before radiation therapy (RT) for post-treatment functional outcome in metastatic spinal cord compression...
  85. ncbi Prognostic value of haemoglobin levels during concurrent radio-chemotherapy in the treatment of oesophageal cancer
    D Rades
    Department of Radiation Oncology, University Hospital Hamburg Eppendorf, Germany
    Clin Oncol (R Coll Radiol) 18:139-44. 2006
    ..To evaluate the prognostic value of haemoglobin levels during radio-chemotherapy for overall survival, metastases-free survival (MFS) and locoregional control in patients with locally advanced oesophageal cancer...
  86. ncbi Therapeutic options for meningeal melanocytoma. Case report
    D Rades
    Department of Radiation Oncology, Hannover Medical College, Germany
    J Neurosurg 95:225-31. 2001
    ..050) and for incomplete resection combined with radiotherapy after 2 years (p = 0.034). Complete tumor resection should be considered the best therapeutic option, followed by incomplete resection combined with postoperative radiotherapy...
  87. ncbi [The value of positron emission tomography (PET) in the treatment of patients with cancer of unknown primary (CUP)]
    D Rades
    Abteilung für Strahlentherapie und spezielle Onkologie, Medizinische Hochschule Hannover
    Strahlenther Onkol 177:525-9. 2001
    ..In the study presented here the value of PET for detection of the primary tumor and a possible dissemination has been investigated and related to therapeutic regimens...
  88. ncbi Late effects and cosmetic results of conventional versus hypofractionated irradiation in breast-conserving therapy
    Fabian Fehlauer
    Department of Radiation Oncology, University Medical Clinic Hamburg Eppendorf, Martinistrasse 52, 20246 Hamburg, Germany
    Strahlenther Onkol 181:625-31. 2005
    ..As the prognosis is general good following BCT, late morbidity and cosmesis are important. The present study compares two different radiation schedules with respect to these two endpoints...
  89. ncbi Effects of irradiation and cisplatin on human glioma spheroids: inhibition of cell proliferation and cell migration
    Fabian Fehlauer
    Department of Radiation Oncology, Universitätsklinikum Eppendorf, University of Hamburg, Martinistr 52, 20254, Hamburg, Germany
    J Cancer Res Clin Oncol 131:723-32. 2005
    ....
  90. ncbi Health-related quality of life in long term breast cancer survivors treated with breast conserving therapy: impact of age at therapy
    Fabian Fehlauer
    Department of Radiation Oncology, University Clinic Hamburg Eppendorf, Germany
    Breast Cancer Res Treat 92:217-22. 2005
    ..Aim was to compare the functional status in long-term breast cancer survivors related to age at diagnosis and to asses the effects of adjuvant therapy on health-related quality of life (HRQoL)...
  91. ncbi Outcome after radiotherapy alone for metastatic spinal cord compression in patients with oligometastases
    Dirk Rades
    Department of Radiation Oncology, University Hospital Schleswig Holstein, Luebeck, Germany
    J Clin Oncol 25:50-6. 2007
    ..To investigate outcome and prognosis of metastatic spinal cord compression (MSCC) patients with oligometastatic disease treated with radiotherapy alone...
  92. ncbi Role of radiotherapy in the treatment of motor dysfunction due to metastatic spinal cord compression: comparison of three different fractionation schedules
    Dirk Rades
    Department of Radiation Oncology, Hannover Medical School, Hannover, Germany
    Int J Radiat Oncol Biol Phys 54:1160-4. 2002
    ..Several reports have compared different fractionation schedules for pain relief. To our knowledge, this retrospective analysis is the first to compare three different schedules for functional outcome...
  93. ncbi Radiotherapy of metastatic spinal cord compression in very elderly patients
    Dirk Rades
    Department of Radiation Oncology, University Hospital Schleswig Holstein, Luebeck, Germany
    Int J Radiat Oncol Biol Phys 67:256-63. 2007
    ..This study investigated the results of radiotherapy (RT) for metastatic spinal cord compression (MSCC) in the very elderly, because few data are available for these patients...
  94. ncbi Locally advanced stage IV squamous cell carcinoma of the head and neck: impact of pre-radiotherapy hemoglobin level and interruptions during radiotherapy
    Dirk Rades
    Department of Radiation Oncology, University Hospital Schleswig Holstein, Campus Luebeck, Luebeck, Germany
    Int J Radiat Oncol Biol Phys 70:1108-14. 2008
    ....
  95. ncbi Whole-brain radiotherapy versus stereotactic radiosurgery for patients in recursive partitioning analysis classes 1 and 2 with 1 to 3 brain metastases
    Dirk Rades
    Department of Radiation Oncology, University Hospital Schleswig Holstein, Campus Luebeck, Germany
    Cancer 110:2285-92. 2007
    ..The authors investigated whether stereotactic radiosurgery (SRS) alone improved outcomes for patients in recursive partitioning analysis (RPA) Classes 1 and 2 who had 1 to 3 brain metastases compared with whole-brain radiotherapy (WBRT)...
  96. ncbi The first score predicting overall survival in patients with metastatic spinal cord compression
    Dirk Rades
    Department of Radiation Oncology, University Hospital Schleswig Holstein, Luebeck, Germany
    Cancer 112:157-61. 2008
    ..The current study was performed to create a scoring system to estimate the survival of patients with metastatic spinal cord compression (MSCC)...
  97. ncbi Evaluation of prognostic factors and two radiation techniques in patients treated with surgery followed by radio(chemo)therapy or definitive radio(chemo)therapy for locally advanced head-and-neck cancer
    Dirk Rades
    Department of Radiation Oncology, University Hospital Schleswig Holstein, Luebeck, Germany
    Strahlenther Onkol 184:198-205. 2008
    ..Comparative studies regarding outcome and toxicity are lacking. This study compared both techniques for overall survival (OS), metastases-free survival (MFS), loco-regional control (LC), and toxicity in stage III/IV head-and-neck cancer...
  98. ncbi Two radiation regimens and prognostic factors for brain metastases in nonsmall cell lung cancer patients
    Dirk Rades
    Department of Radiation Oncology, University Hospital Schleswig Holstein, Luebeck, Germany
    Cancer 110:1077-82. 2007
    ..A short course of WBRT would be preferable to longer regimens if it could provide similar survival. This retrospective study of NSCLC patients compared longer treatment programs with short-course WBRT with 5 x 4 Gy given during 5 days...
  99. ncbi Prognostic factors in the nonsurgical treatment of esophageal carcinoma with radiotherapy or radiochemotherapy: the importance of pretreatment hemoglobin levels
    Dirk Rades
    Department of Radiation Oncology, University Hospital Hamburg Eppendorf, Hamburg, Germany
    Cancer 103:1740-6. 2005
    ..The current study was performed to evaluate prognostic factors for overall survival (OS), distant metastasis (DM), and local failure (LF) in patients with Stage II/III esophageal carcinoma...
  100. ncbi Dose escalation of whole-brain radiotherapy for brain metastases from melanoma
    Dirk Rades
    Department of Radiation Oncology, University Hospital Schleswig Holstein, Lubeck, Germany
    Int J Radiat Oncol Biol Phys 77:537-41. 2010
    ..Hypofractionation regimens failed to improve the outcome of these patients. This study investigates a potential benefit from escalation of the WBRT dose beyond the "standard" regimen 30 Gy in 10 fractions (10x3 Gy)...
  101. ncbi [Bilateral breast carcinoma and local recurrence: prevalence of BRCA-1 and BRCA-2 gene mutations in an unselected patient sample]
    M Bremer
    Abteilung für Strahlentherapie und spezielle Onkologie, Medizinische Hochschule Hannover
    Strahlenther Onkol 177:325-9. 2001
    ....